ECU offers innovative and practical courses across a variety of disciplines and we have a vibrant research culture. ECU is a leader in developing alternative entry pathways to higher education.
We have three campuses in Western Australia. Joondalup and Mount Lawley in the Perth metropolitan area and our South West campus in Bunbury, 200km south of the Perth CBD.
ECU provides a variety of services and facilities that go beyond the classroom, with opportunities for personal development and social interaction for students and staff.
We collaborate with all types of businesses, including new start-ups, small to medium enterprises, not-for-profits, community organisations, government and large corporates in the resources sector.
Children's University Edith Cowan aims to inspire students between seven and fourteen to develop confidence and a love of learning through validated activities beyond the school curriculum.
The Inspiring Minds scholarship program are equity scholarships that give students an opportunity to access an education that may otherwise be out of reach.
Xingang is a Postdoctoral Research Fellow in the School of Medical and Health Sciences, within the Suboptimal Health and Glycomics research group. He is also a research member of the Centre for Precision Health, an ECU Strategic Research Centre.
Qualifications
Doctor of Philosophy, Edith Cowan University, 2020.
Master of Medicine, China (excludes SARs and Taiwan), 2008.
Bachelor of Medicine, China (excludes SARs and Taiwan), 2001.
Wu, Z., Zhang, H., Xu, Y., Li, X., Li, X., Balmer, L., Guo, X., Zhang, Q., Han, X., Tao, L. (2024). Low Remnant Cholesterol and In‐Hospital Bleeding Risk After Ischemic Stroke or Transient Ischemic Attack. Journal of the American Heart Association, 13(14), Article number e034307. https://doi.org/https://doi.org/10.1161/JAHA.124.034307.
Guo, Z., Zheng, Y., Geng, J., Wu, Z., Wei, T., Shan, G., Zhu, Y., Zheng, Y., Li, X. (2024). Unveiling the link between systemic inflammation markers and cognitive performance among older adults in the US: A population-based study using NHANES 2011–2014 data. Journal of Clinical Neuroscience, 119(2024), 45-51. https://doi.org/10.1016/j.jocn.2023.11.004.
Yang, L., Yan, Y., Li, J., Zhou, C., Jin, J., Zhang, T., Wu, H., Li, X., Wang, W., Yuan, L., Zhang, X., Gao, J. (2023). (Tn5-) FISH-based imaging in the era of 3D/spatial genomics. Biophysics Reports, 9(1), 15-25. https://doi.org/10.52601/bpr.2023.220025.
Lan, Y., Wu, D., Cai, Z., Xu, Y., Ding, X., Wu, W., Lan, S., Chen, L., Guo, Z., Balmer, L., Li, X., Song, M., Wu, S., Gao, J., Wang, W., Chen, Y. (2023). Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study. Cardiovascular Diabetology, 22(1), Article number 181. https://doi.org/10.1186/s12933-023-01878-5.
Wang, Y., Guo, Z., Tian, Y., Cong, L., Zheng, Y., Wu, Z., Shan, G., Xia, Y., Zhu, Y., Li, X., Song, Y. (2023). MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor. BMC Cancer, 23(1), article number 959. https://doi.org/10.1186/s12885-023-11480-3.
Lan, Y., Chen, G., Wu, D., Ding, X., Huang, Z., Wang, X., Balmer, L., Li, X., Song, M., Wang, W., Wu, S., Chen, Y. (2023). Temporal relationship between atherogenic dyslipidemia and inflammation and their joint cumulative effect on type 2 diabetes onset: a longitudinal cohort study. BMC Medicine, 21(1), Article number 31. https://doi.org/10.1186/s12916-023-02729-6.
Wang, H., Wang, Y., Li, X., Deng, X., Kong, Y., Wang, W., Zhou, Y. (2022). Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort. Cardiovascular Diabetology, 21(1), article number 288. https://doi.org/10.1186/s12933-022-01716-0.
Zheng, Y., Guo, Z., Zhang, Y., Shang, J., Yu, L., Fu, P., Liu, Y., Li, X., Wang, H., Ren, L., Zhang, W., Hou, H., Tan, X., Wang, W. (2022). Rapid triage for ischemic stroke: a machine learning‑driven approach in the context of predictive, preventive and personalised medicine. EPMA Journal, 13(2), 285-298. https://doi.org/10.1007/s13167-022-00283-4.
Guo, Z., Meng, R., Zheng, Y., Li, X., Zhon, Z., Yu, L., Tang, Q., Zhao, Y., Garcia, M., Tan, Y., Song, M., Balmer, L., Wen, J., Hou, H., Tan, X., Wang, W. (2022). Translation and cross-cultural validation of a precision health tool, the Suboptimal Health Status Questionnaire-25, in Korean. Journal of Global Health, 12(1 October 2022), Article Number 04077. https://doi.org/10.7189/jogh.12.04077.
Yang, J., Chen, T., Zhu, Y., Bai, M., Li, X. (2021). Causal Inference Between Chronic Periodontitis and Chronic Kidney Disease: A Bidirectional Mendelian Randomization Analysis in a European Population. Frontiers in Genetics, 12(7 June 2021), Article number 676136. https://doi.org/10.3389/fgene.2021.676136.
Meng, X., Song, M., Vilaj, M., Štambuk , J., Dolikun, M., Zhang, J., Liu, D., Wang, H., Zhang, X., Zhang, J., Cao, W., Momčilović , A., Trbojević-Akmačić , I., Li, X., Zheng, D., Wu, L., Guo, X., Wang, Y., Lauc, G., Wang, W. (2021). Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese. Journal of Personalized Medicine, 11(7), Article number 614. https://doi.org/10.3390/jpm11070614.
Wang, H., Tian, Q., Zhang, J., Liu, H., Zhang, J., Cao, W., Zhang, X., Li, X., Wu, L., Song, M., Kong, Y., Wang, W., Wang, Y. (2021). Blood transcriptome profiling as potential biomarkers of suboptimal health status: potential utility of novel biomarkers for predictive, preventive, and personalized medicine strategy. EPMA Journal, 12(2), 103-115. https://doi.org/10.1007/s13167-021-00238-1.
Li, X., Wang, H., Zhu, Y., Cao, W., Song, M., Wang, Y., Hou, H., Lang, M., Guo, X., Tan, X., Han, J., Wang, W. (2021). Heritability Enrichment of Immunoglobulin G N-Glycosylation in Specific Tissues. Frontiers in Immunology, 12(3 November 2021), article number 741705. https://doi.org/10.3389/fimmu.2021.741705.
Li, X., Wang, L., Tan, X., Wang, W. (2020). Genome plasticity and endocrine diseases. Genome Plasticity in Health and Disease (211-235). Academic Press. https://ro.ecu.edu.au/ecuworkspost2013/8229.
Journal Articles
Wang, H., Tian, Q., Zhang, J., Liu, H., Zhang, X., Cao, W., Zhang, J., Anto, E., Li, X., Wang, X., Liu, D., Zheng, Y., Guo, Z., Wu, L., Song, M., Wang, Y., Wang, W. (2020). Population-based case-control study revealed metabolomic biomarkers of suboptimal health status in Chinese population—potential utility for innovative approach by predictive, preventive, and personalized medicine. EPMA Journal, 11(2), 147-160. https://doi.org/10.1007/s13167-020-00200-7.
Li, X., Wang, H., Russell, A., Cao, W., Wang, X., Ge, S., Zheng, Y., Guo, Z., Hou, H., Song, M., Yu, X., Wang, Y., Hunter, M., Roberts, P., Lauc, G., Wang, W. (2019). Type 2 Diabetes Mellitus is Associated with the Immunoglobulin G N-Glycome through Putative Proinflammatory Mechanisms in an Australian Population. OMICS: A Journal of Integrative Biology, 23(12), 631-639. https://doi.org/10.1089/omi.2019.0075.
Wang, H., Li, X., Wang, X., Liu, D., Zhang, X., Cao, W., Zheng, Y., Guo, Z., Li, D., Xing, W., Hou, H., Wu, L., Song, M., Zhong, Z., Wang, Y., Tan, X., Lauc, G., Wang, W. (2019). Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin G N-Glycans in a Chinese Han Population. OMICS: A Journal of Integrative Biology, 23(12), 649-659. https://doi.org/10.1089/omi.2019.0099.
Cao, F., Li, X., Yang, Y., Fang, H., Qu, H., Chang, N., Ma, Q., Cao, W., Zhou, J., Wang, W. (2019). Toward Candidate Proteomic Biomarkers in Clinical Monitoring of Acute Promyelocytic Leukemia Treatment with Arsenic Trioxide. OMICS: A Journal of Integrative Biology, 23(2), 119-130. https://doi.org/10.1089/omi.2018.0178.
Ma, Q., Adua, E., Boyce, M., Li, X., Ji, G., Wang, W. (2018). IMass time: The future, in future!. OMICS: A Journal of Integrative Biology, 22(11), 679-695. https://doi.org/10.1089/omi.2018.0162.
Research Projects
B Cell Regulation of Immunoglobulin G N-Glycosylation in Crohn's Disease, Department of Health WA, WA Near-miss Awards: Emerging Leaders Program, 2024 ‑ 2025, $100,000.
Developing a tool to predict the likely occurrence of stroke, Edith Cowan University, Early-Mid Career Researcher Grant Scheme 2022 (Stream 1), 2023 ‑ 2024, $39,571.
Exploring the Potential for Intervening the Rise in the Prevalence of Chronic Disease in South-West Australia, WA Primary Health Alliance, Grant, 2017 ‑ 2018, $18,954.
Doctor of Philosophy, Exploring Moderator and Mediator Effects of Suboptimal Health Status and Multi-omics Signatures for Metabolic Syndrome: A Nested Case-Control Study and Post-GWAS Integrative Analysis
Doctor of Philosophy, Unravelling Type 2 Diabetes Biomarkers Through Advance Single-Cell RNA Sequencing and N-Glycome Profiling.
Doctor of Philosophy, Data mining for dementia prevention using mobile phone applications (the PRODEMOS study) in China: A multicentre randomised controlled effectiveness-implementation trial
Doctor of Philosophy, Development and External Validation of a Novel Prognostic Model for Aortic-related Adverse Events after Endovascular Repair in Patients with Type B Aortic Dissection
Doctor of Philosophy, Exploring the Impact of Uterine Fibroids on Hypertension through Hypoxia-Inducible Factor-1 alpha-Medicated Regulation of Endothelin-1 and Soluble Fms-like Tyrosine Kinase 1 in Hypoxic Leiomyoma Smooth Muscle Cells
Doctor of Philosophy, Development and External Validation of a Novel Prognostic Model for Adverse Events after Endovascular Treatment in Patient with Ruptured Intracranial Aneurysm
Doctor of Philosophy, Investigating the Role of IgG N-glycosylation in Diagnosis and Disease Activity of Axial Spondyloarthritis
Doctor of Philosophy, Artificial intelligence-assisted prediction, feature, selection, and multi-omics integration in exploing the interaction between IgG N-glycome and transcriptome and constructing the ageing clock
Doctor of Philosophy, The role of CD147 N-glycosylation and IgG N-glycosylation in the inflammatory modulation of atherogenesis
Assistant Supervisor
Doctor of Philosophy, Inflammation, metabolic disorders and incident type 2 diabetes
Help us improve our content
Please leave a comment about your rating so we can better understand how we might improve the page.